Maria M. Gabriel retweeted
Is normal pressure hydrocephalus (NPH) over-diagnosed? YES. When appropriately diagnosed and treated can some symptoms improve w/ shunting. YES. Nice article by Akter and colleagues to help clinicians on their journey to sort this out.
Key points:
- NPH: think ventriculomegaly in the absence of structural blockage of the CSF.
- Famous triad of cognitive impairment, gait disturbance and urinary incontinence.
- A detailed cognitive assessment, neurologic examination and brain imaging should be carefully performed to exclude alternative causes and confirm the diagnosis. The key word is multidisciplinary.
- Many experts recommend high-volume lumbar puncture or a lumbar drain. Watching gait pre- and post LP can be tricky and watch out for placebo effects.
My take: Any clinician who is overconfident on the diagnosis of NPH will be humbled and burned at some point. Workup's should be slow and deliberate and there should be shared decision making if a shunt is considered as there are both complications and also concerns over longevity of response. Levodopa treatment may be appropriate in some cases. Nice recent articles by @AlbertoEspay @DrAlfonsoFasano and Bluett. and others go deep on thinking about the complexities of NPH.
cmaj.ca/content/195/3/E115
movementdisorders.onlinelibr…
movementdisorders.onlinelibr… #NPH #Parkinson
Maria M. Gabriel retweeted
📍Last chance to register for the fourth #IshenTranslational presentation series:
📅When: Tuesday, 7th of December 2023, at 10am EST (3pm UK time).
⬇️Click here to register⬇️
epfl.zoom.us/meeting/registe…
Maria M. Gabriel retweeted
This study found that individuals with rare NOTCH3 variants have a distinct pattern of brain parenchymal damage related to cerebral small vessel disease. Learn more: bit.ly/3QNO83M
#NeuroTwitter #Genetics
Maria M. Gabriel retweeted
Via @JAMANeuro: Why do some people remain free of clinical signs of dementia despite having amyloid-beta plaques and neurofibrillary tangles? A post-mortem brain analysis offers new evidence: bit.ly/47cUikB
#NeuroTwitter @HarvardMed @TSpiresJones @YoungPearseLab @ElzHead
Maria M. Gabriel retweeted
Excited to share our work on autoantibodies against CXCR3 and their relation to cardiovascular disease - out now 🎯
Many thanks to all the fantastic contributors for making this collaborative effort possible! 🧵
@cardiogenetics @RheumaImmu_HL
🔗academic.oup.com/eurheartj/a…
Maria M. Gabriel retweeted
Happy to share our current review on the evidence in treatment of ischemic stroke (in German)
link.springer.com/article/10…
@MHH_life @SpringerMedizin @Johanna_Ernst_ @kai_schmidt_ott @PRACTIS_MHH
Maria M. Gabriel retweeted
The TENSION trial shows that thrombectomy reduces disability and mortality in pts. with large infarct core in the ext. time window and that sophisticated imaging methods are not strictly mandatory to guide this therapy.
@TENSIONstudy @ESOstroke @CSI_Lab
eso-stroke.org/mechanical-th…
Driveline infection in patients under LVAD therapy increases the risk for vessel wall inflammation, stroke and mortality: nature.com/articles/s41598-0… #lvad #fdgpet #nature #artificialhearts
Maria M. Gabriel retweeted
🌊🩸MRI features of ARIA
(Amyloid-Related Imaging Abnormalities)
🧠Associated with the use of monoclonal antibodies that target Aβ for Alzheimer's disease
💡ARIA=iatrogenic CAA-related inflammation
#neurotwitter #NeuroTwitter #NeuroRad #MedTwitter #MedStudentTwitter #MedEd #EndNeurophobia #Neurology #Neurosurgery #RadEd #stroke #Alzheimers #dementia #lecanemab #amyloidangiopathy
Maria M. Gabriel retweeted
We are ending our morning session with two great and informative talks by @alena_eh3 on diagnosing mHE: comparison of 6 frequently used tests and Julius Egge on the impact of alcohol etiology of liver cirrhosis upon mHE diagnosis #ishen2023
Congrats to out president @KarinWeissenb ! Enjoying the beautiful #ishen2023 Congress at Bad Zwischenahn, Germany with interesting updates in #he @Maasoumy_lab @alena_eh3 @gerritgrosse @RSchuppner
Maria M. Gabriel retweeted
The ISHEN 2023 Symposium provides an outstanding update on research and clinical implications of HE and a fantastic social program in the beautiful landscape of Bad Zwischenahn! Register now at:
ishen.org
@ISHENliver
@MHH_life
@idw_online_de
@dgn_ev
@KarinWeissenb
Maria M. Gabriel retweeted
People are talking about: As it becomes increasingly clear just how central the neurovasculature is in clearance of amyloid and other proteins, a new term, “neurovasculome,” has entered the lexicon: bit.ly/458LnQ0
#NeuroTwitter @AANMember
We present a 48-year-old woman suffering two spontaneous intracranial lobar hemorrhages. Do you consider recently proposed diagnostic criteria for iatrogenic CAA in your diagnostic routine? #CAA #amyloid @BenStorti @MHH_life #EJoN
pubmed.ncbi.nlm.nih.gov/3749…
Maria M. Gabriel retweeted
Just published in @JAHA_AHA: ahajournals.org/doi/10.1161/…
In this systematic literature review, we provide an overview on the current evidence on how genetic variants may help to elucidate the actual mechanism of cryptogenic #stroke. @Johanna_Ernst_ @MHH_life @PRACTIS_MHH @dfg_public
The clinical spectrum of cerebral amyloid angiopathy (CAA) is increasingly expanding. Proud to keep the track with Fondazione IRCCS Istituto Neurologico Carlo Besta @BenStorti @frontiers frontiersin.org/articles/10.…
2
165
Maria M. Gabriel retweeted
The first analysis of the multicenter PRODAST study is now online OA! Early application of dabigatran after stroke ist likely safer than vit. K antagonists with regards to hemorrhagic complications, especially ICH. @unidue @MHH_life @IntJStroke
@WorldStrokeOrg @ESOstroke
Just Accepted!
📰Early or late initiation of #dabigatran versus vitamin-k-antagonists in acute ischemic #stroke or #TIA - the PRODAST study.
journals.sagepub.com/doi/abs… @gerritgrosse
Un unforgetable and exciting 4-month stage at the Cerebrovascular Disease Unit of IRCCS Foundation C Besta in Milan is over. Can’t express all my gratitude to Dr.Anna Bersano, her amazing team (@BenStorti) and @ESOstroke for the support! Check my report on eso-stroke.org/resources/dep…
Hepatic Encephalopathy remains a severe complication in patients after transjugular intrahepatic portosystemic shunt. In this study, @Maasoumy_lab evaluated three tools frequently used for diagnosing mHE for their predictive value for overt HE after TIPS: bit.ly/3JA3Axy






















